30,427例结直肠癌手术16年演变:内镜筛查对病例复杂度的影响
该研究回顾性分析复旦大学附属肿瘤医院2008至2023年连续30,427例结直肠癌手术病例,按三个时期分层。结果显示手术人群趋向老龄化和复杂化,早期病例占比下降而高级别上皮内瘤变腺瘤比例上升,腹腔镜应用大幅增加,微创技术成熟维持了肿瘤学清扫质量。
要点
- 手术结直肠癌人群呈老龄化趋势,≥65岁患者比例从27.4%升至39.4%。
- 疑似内镜过滤效应:手术Stage 0-I比例从20.3%降至12.4%,腺瘤伴高级别上皮内瘤变从1.5%升至12.3%。
- 腹腔镜从0.2%增至64.5%,平均淋巴结检出数从15.4升至16.9(P<0.001)。
核心结论
- 手术结直肠癌病例向老龄、复杂、局部进展期转变,与内镜早期病例分流一致。
- 尽管人口学负担增加,微创技术成熟维持了高质量肿瘤学清扫。
- 校正年龄、性别、分期、肿瘤部位和手术方式后,最近时期生存与历史基线相当(HR=1.049,95%CI 0.976-1.128,P=0.194)。
研究设计与样本
- 单中心回顾性分析2008至2023年连续30,427例结直肠癌切除术患者。
- 按三个时期分层:Era 1(开放手术为主,2008-2012)、Era 2(过渡期,2013-2017)、Era 3(微创为主,2018-2023)。
- 分析人口学、肿瘤形态、分期分布、淋巴结检出数和5年总生存趋势。
主要发现
- 手术管理的小于50岁早发性结直肠癌比例从2008年24.8%降至2023年14.6%,≥65岁患者从27.4%升至39.4%(P<0.001)。
- 手术Stage 0-I病例比例从20.3%降至12.4%,腺瘤伴高级别上皮内瘤变从1.5%升至12.3%。
- 平均肿瘤直径呈J形轨迹:2012年4.20 cm降至2014年最低3.80 cm,2023年回升至4.20 cm。
- 腹腔镜从0.2%增至64.5%;平均淋巴结检出数从Era 1的15.4升至Era 3的16.9(P<0.001)。
- 2023年腹腔镜组平均淋巴结检出数16.3±6.8,开放组15.6±7.7(P=0.067)。
临床怎么用
- 结直肠癌手术人群老龄化与复杂化趋势下,应重视围术期风险管理和个体化评估。
- 微创技术成熟可在复杂病例中维持淋巴结清扫质量,支持腹腔镜在结直肠癌手术中的常规应用。
- 内镜早期分流可能改变外科病例结构,外科应关注高级别上皮内瘤变腺瘤等特殊病理类型的手术决策。
局限性
- 单中心回顾性设计,结论外推需谨慎。
- Era 3生存下降可能与人群更老、病例更复杂有关,原文未明确因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While global registries report a rising incidence of early-onset colorectal cancer (EOCRC), the impact of widespread screening and endoscopic therapeutics on the case-mix of major surgical centers remains undercharacterized. We aimed to quantify the 16-year evolution of surgical demographics, pathological profiles, and quality metrics to delineate how modern practice reshapes surgical volume and outcomes. METHODS: We conducted a retrospective analysis of 30,427 consecutive patients undergoing colorectal cancer (CRC) resection at Fudan University Shanghai Cancer Center from 2008 to 2023. The cohort was stratified into three eras: Era 1 (Open-predominant, 2008-2012), Era 2 (Transitional, 2013-2017), and Era 3 (Minimally Invasive-predominant, 2018-2023). Trends in demographics, tumor morphology, stage distribution, lymph node yield, and 5-year overall survival (OS) were analyzed. RESULTS: Contrary to global incidence trends, the proportion of surgically managed EOCRC (< 50 years) declined from 24.8% in 2008 to 14.6% in 2023, while patients aged ≥ 65 years increased from 27.4 to 39.4% (P < 0.001). A pattern consistent with a hypothesized "endoscopic filtering effect" was observed: the proportion of surgical Stage 0-I cases contracted from 20.3 to 12.4%, while adenoma with high-grade intraepithelial neoplasia (HGIN) rose dramatically from 1.5 to 12.3%. Mean tumor diameter exhibited a "J-shaped" trajectory: decreasing from 4.20 cm in 2012 to a nadir of 3.80 cm in 2014, before rebounding to 4.20 cm by 2023. Surgically, laparoscopy adoption surged from 0.2 to 64.5%. This transition was accompanied by a steady increase in mean lymph node yield, rising from 15.4 in Era 1 to 16.9 in Era 3 (P < 0.001). In 2023, the mean lymph node yield in the laparoscopic group (16.3 ± 6.8) was numerically superior to the open surgery group (15.6 ± 7.7; P = 0.067). Regarding prognosis, 5-year OS peaked during the transitional period (Era 2: 75.9%). Although OS declined in Era 3 (69.5%) concurrent with the shift toward an older and more complex case-mix, outcomes remained robust and comparable to the historical baseline (Era 1: 73.0%). CONCLUSIONS: The landscape of surgical CRC has shifted toward an older population with more complex, locally advanced disease, a pattern consistent with upstream endoscopic diversion of early-stage cases. Despite this increased demographic burden, the maturation of minimally invasive techniques has maintained high-quality oncological clearance, as evidenced by improving lymph node yield and declining circumferential resection margin (CRM) positivity rates. After adjusting for age, sex, stage, tumor location, and surgical approach, survival outcomes in the most recent era were comparable to the historical baseline (HR = 1.049, 95% CI 0.976-1.128, P = 0.194).
引用
- Lu Z, Tang J, Hu S, et al. Shifting paradigms in 30,427 surgical colorectal cancer cases (2008-2023): the impact of endoscopic screening on caseload complexity and the value of minimally invasive quality. Surg Endosc. 2026. PMID: 42257954. doi:10.1007/s00464-026-12818-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。